chr15-65077176-G-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001101362.3(KBTBD13):āc.361G>Cā(p.Val121Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000884 in 1,504,330 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V121M) has been classified as Benign.
Frequency
Consequence
NM_001101362.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000513 AC: 78AN: 151968Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000472 AC: 5AN: 105916Hom.: 0 AF XY: 0.0000339 AC XY: 2AN XY: 58934
GnomAD4 exome AF: 0.0000399 AC: 54AN: 1352252Hom.: 1 Cov.: 56 AF XY: 0.0000330 AC XY: 22AN XY: 666236
GnomAD4 genome AF: 0.000519 AC: 79AN: 152078Hom.: 0 Cov.: 34 AF XY: 0.000484 AC XY: 36AN XY: 74366
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.361G>C (p.V121L) alteration is located in exon 1 (coding exon 1) of the KBTBD13 gene. This alteration results from a G to C substitution at nucleotide position 361, causing the valine (V) at amino acid position 121 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
KBTBD13-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Nemaline myopathy 6 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at